Gary A. Lyons

Who is Gary A. Lyons?

Gary A. Lyons has served as President, Chief Executive

Officer and as a member of the Board of Directors since joining the

Company in February 1993. Prior to joining Neurocrine, Mr. Lyons held a

number of senior management positions at Genentech including Vice

President of Business Development and Vice President of Sales as well

as being a member of Genentech's Executive Committee. He was

responsible for international licensing, acquisitions and partnering,

was responsible for Genentech's Corporate Venture Program and had

operating responsibility for Genentech's two subsidiaries, Genentech

Canada, Inc. and Genentech Limited (Japan). Previously he served as

Vice President of Sales and was responsible for building the marketing

and sales organization for the commercial introduction of Genentech's

first two pharmaceutical products, Protropin (human growth hormone) and

Activase (TPA). Mr. Lyons currently serves on the Board of Directors of

Intrabiotics Pharmaceuticals, Inc. and Vical, Inc. Mr. Lyons holds a

B.S. in marine biology from the University of New Hampshire and an

M.B.A. from Northwestern University's J.L. Kellogg Graduate School of

Management.